If you’ve ever felt that sudden, overwhelming wave of heat—the telltale sign of a hot flash—you know how disruptive and ...

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

Postmenopausal women with a history of hormone therapy use have slower biological aging compared to those who never used the ...

This article reviews the published literature on the use of venlafaxine, fluoxetine, and paroxetine for the treatment of hot flashes.

Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...

New research published in Menopause, the journal of The Menopause Society, found a possible link between severe menopause ...

which included information on individual patient treatment assignment (placebo versus active agent), dose and the frequency and severity of hot flashes. Daily hot flash frequency was multiplied by ...

Midlife women with a metabolic dysfunction-associated steatotic liver disease diagnosis were more likely to report severe or ...

Ever since breast cancer treatments pushed me into sudden and premature induced menopause at 37 years old, I’ve suffered ...

As Bayer awaits an FDA decision on its non-hormonal treatment for hot flashes caused by menopause, it's unveiling new results ...

The transition to menopause isn't always easy. Menopause — which usually occurs at around age 50 — officially begins 12 ...

Vasomotor symptoms are a common problem in women with HR-positive breast cancer receiving anti-cancer therapy.